Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowSeventh Circuit Court of Appeals
Teva Pharmaceuticals USA Inc. v. Eli Lilly and Co.
No. 25-2125
Civil. Appeal from the United States District Court for the Southern District of Indiana, Judge Matthew P. Brookman. Reverses the district court’s dismissal of generic drug manufacturer Teva’s breach-of-contract claim and remands for further proceedings. The court ruled that Teva plausibly alleged breaches of the settlement agreement between it and Lilly regarding the entry of a generic version of osteoporosis drug Forteo, concluding that the agreement’s terms could be interpreted as still in effect despite the expiration of the relevant patents. Judge Hamilton authored the opinion. Judges Jackson-Akiwumi and Kolar concur. Appellant’s attorneys: Darren A. Craig and Kandi Kilkelly Hidde, FBT Gibbons, Indianapolis; Christopher Holding, Brian Timothy Burgess and Jesse Lempel, Goodwin Procter, Boston. Apellee’s attorneys: Melissa Arbus Sherry, Mark Zubick and Gabriel K. Bell, Latham & Watkins, Washington, D.C.; Deborah Pollack-Milgate, Barnes & Thornburg, Indianapolis.
This content was created with the assistance of artificial intelligence and has been reviewed by an editor for accuracy.
Please enable JavaScript to view this content.